Evidence receipt / belief
Published · transcript-backedDavid Rosenthal: belief
22 Jan 2024 Acquired Novo Nordisk (Ozempic)
“Anyway, right around this same time, Novo begins phase three trials with their new, next generation, improved GLP-1 analogue, Semaglutide. which I think is pronounced Semaglutide.”
Source trail
Everything needed to verify it.
- Speaker
- David Rosenthal
- Attribution
- Verified speaker
- Claim type
- belief
- Recorded
- 22 Jan 2024
- Publisher
- Acquired
- Episode
- Novo Nordisk (Ozempic)
Transcript context
…It's crazy. Anyway, right around this same time, Novo begins phase three trials with their new, next generation, improved GLP-1 analogue, Semaglutide. which I think is pronounced Semaglutide. We've also heard Semaglutide. We did an obscene amount of Research on this and don't have a good answer. So if you know, get in touch with us. The most reputable source we could find seemed to say Semaglutide.…
Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.